MedPath

Genetics of Type 1 Diabetes in Chinese Adolescents and Youth

Conditions
Diabetes Mellitus
Registration Number
NCT01938365
Lead Sponsor
Shanghai Jiao Tong University School of Medicine
Brief Summary

primary outcome: To explore the genetic susceptibility of diabetes in Chinese adolescent and youth.

secondary outcomes:

1. To classify diabetes by gene detection in Chinese adolescent and youth.

2. To make the relationship between genotype and clinic phenotype in type 1 diabetes.

3. To evaluate the effect of environmental factors (intestinal ecosystem)in the pathogenesis of diabetes.

Detailed Description

Phase 1: Baseline investigation Aims: To explore genetic susceptibility of diabetes in Chinese adolescent and youth.

Subjects and Methods: 500 patients under diabetic conditions and sex,age-matched NGR Healthy control(2:1) will be enrolled ,all aged from 14-30 years old. A comprehensive examination including questionnaire, anthropometric measurements, biochemical analysis will be performed in each study participant. Diabetes should be diagnosed according to the WHO 1999 criteria,type 1 or type 2 diabetes diagnosed by clinical features recommended by International Society of Pediatric and Adolescent Diabetes ( ISPAD ).

Phase 2: Cohort follow-up Aims : To explore the association of genetic backgrounds and clinical characteristics in different types of diabetes in Chinese adolescent and youth.

Subjects and Methods: To recruit and follow up 200 newly diagnosed and genotyped patients for 3 years. Questionnaire, anthropometric measurements, biochemical analysis performed respectively at baseline,3,6,12,24,36 months after enrollment.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria
  1. Age: 14- 30 years old
  2. Gender: males and females
  3. Race: han
  4. Diabetes diagnosed by WHO cafeteria (WHO1999)
  5. Living in east China area to minimize population stratification
Exclusion Criteria
  1. Secondary diabetes caused by other diseases or drugs
  2. Moderate to severe liver, kidney dysfunction, i.e. ALT/AST > 2.5 times the upper limit of normal range or Ccr < 25ml/min;
  3. Any other condition or major systemic diseases that the investigator feels would interfere with trial participation or evaluation of results.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Deterioration of pancreatic islet function3 years
Secondary Outcome Measures
NameTimeMethod
Insulin dosage, HbA1c levels and evaluation of chronic complications3 years

Trial Locations

Locations (1)

Ruijin hospital, Shanghai Jiao-Tong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath